<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Genomic changes frequently occur in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells during <z:mp ids='MP_0002006'>tumorigenesis</z:mp> from <z:mpath ids='MPATH_458'>normal</z:mpath> cells </plain></SENT>
<SENT sid="1" pm="."><plain>Using the Illumina Human NS-12 single-nucleotide polymorphism (SNP) chip to screen for gene copy number changes in primary <z:hpo ids='HP_0001402'>hepatocellular carcinomas</z:hpo> (<z:mp ids='MP_0003331'>HCCs</z:mp>), we initially detected amplification of 35 genes from four genomic regions (1q21-41, 6p21.2-24.1, 7p13 and 8q13-23) </plain></SENT>
<SENT sid="2" pm="."><plain>By integrated screening of these genes for both DNA copy number and gene expression in <z:mp ids='MP_0003331'>HCC</z:mp> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, we selected CENPF (centromere protein F/mitosin), GMNN (geminin, DNA replication inhibitor), CDK13 (cyclin-dependent kinase 13), and FAM82B (family with sequence similarity 82, member B) as common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> genes </plain></SENT>
<SENT sid="3" pm="."><plain>Each gene exhibited an amplification frequency of ~30% (range, 20-50%) in primary <z:mp ids='MP_0003331'>HCC</z:mp> (n = 57) and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (n = 12), as well as in a panel of human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell lines (n = 70) </plain></SENT>
<SENT sid="4" pm="."><plain>Clonogenic and invasion assays of NIH3T3 cells transfected with each of the four amplified genes showed that CENPF, GMNN, and CDK13 were highly oncogenic whereas FAM82B was not </plain></SENT>
<SENT sid="5" pm="."><plain>Interestingly, the oncogenic activity of these genes (excluding FAM82B) was highly correlated with gene-copy numbers in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples (correlation coefficient, r&gt;0.423), indicating that amplifications of CENPF, GMNN, and CDK13 genes are tightly linked and coincident in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, we confirmed that CDK13 gene copy number was significantly associated with clinical <z:hpo ids='HP_0003674'>onset</z:hpo> age in patients with <z:mp ids='MP_0003331'>HCC</z:mp> (P = 0.0037) </plain></SENT>
<SENT sid="7" pm="."><plain>Taken together, our results suggest that coincidently amplified CDK13, GMNN, and CENPF genes can play a role as common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-driver genes in human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
</text></document>